올릭스
Edit

올릭스

http://www.olixpharma.com/
Last activity: 06.02.2023
Probably Closed
Categories: BioTechDevelopmentDrugHealthTechHumanIndustryMedtechPlatformScienceTechnology
Mentions
1
Location: South Korea, Suwon-si
Total raised: $37.51M

Investors 3

Funding Rounds 1

DateSeriesAmountInvestors
01.12.2020-$37.51M-

Mentions in press and media 1

DateTitleDescription
08.04.2022OliX Pharmaceuticals Identifies Inhibition of Target Gene Expression in Nonhuman Primate Models for NASH CandidateIdentified knockdown of target genes for the NASH treatment candidate Reduction of ALT and AST liver marker levels observed in monkey models Company to present results at the 2022 Academic Symposium of the Korean Endocrine Society SUWON, So...

Reviews 0

Sign up to leave a review

Sign up Log In